Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as
Case Western Reserve´s new vice president for research, effective this month.
Rivera, the university´s associate vice president for research since January 2011,
emerged as the top choice after an extensive process involving campuswide nominations
of internal university candidates. Since coming to CWRU, Rivera has distinguished herself
through a commitment to collaboration and a focus on systems and processes.
Read more about her.
Click here to view previous editions of Research Matters and Research News and Updates.
December 9, 2014
The Ohio Clinical Trial Collaborative (OCTC)
The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.
The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.
Contact Joe Peter at 216-702-5314 for more information.
Parkinson’s Disease Foundation
Are you interested in further Parkinson’s science? Join the Parkinson’s Disease Foundation (PDF) team by becoming a PDF-funded research, clinician, or fellow.
Visit the PDF website for more information on the 2014-2015 PDF Grant Program deadlines.
NIH Change to annual progress reports received on/after 10/1/14
National Institutes of Health (NIH) annual progress reports received on or after October 1, 2014 must include a section to describe how individual development plans (IDPs) are used to identify and promote the career goals of graduate students and postdoctoral researchers associated with the award.
The CTSC Annual Pilot Program is for researchers to conduct innovative translational research projects focused on the invention, preclinical development and/or first in man studies of novel therapeutic agents, biomedical devices, and diagnostics designed to address unmet clinical needs. Funding is intended to facilitate development of enabling technologies; new therapeutic, diagnostic or outcomes assessment approaches and/or device; novel cross-disciplinary collaborative programs; and promote research in the community.
Research which may create intellectual property is encouraged. If funding would enhance an existing non-federally funded project or enable a proposal to a federal agency for use of CTSC and CCTRP resources, the application would be considered. This pilot has few restrictions and allows for the hiring of personnel. Researchers new to clinical research, clinical research scholars, or experienced researchers who are moving into a new area of research are strongly encouraged to apply.
Available Funds: Up to $50,000 per project for up to one year of support.
Deadline for Letter of Intent: January 15, 2015.
For questions contact:
CTSC Pilot Program Office:
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be